# Hypothermia Enhanced by Magnesium Sulphate

> **NCT02499393** · PHASE2,PHASE3 · COMPLETED · sponsor: **Polish Mother Memorial Hospital Research Institute** · enrollment: 75 (actual)

## Conditions studied

- Perinatal Anoxic-ischemic Brain Injury

## Interventions

- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT02499393
- **Lead sponsor:** Polish Mother Memorial Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-04
- **Final completion:** 2014-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2015-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02499393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02499393, "Hypothermia Enhanced by Magnesium Sulphate". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02499393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*